Gilead sees 33% revenues will come from oncology by 2030 https://www.fiercepharma.com/pharma/gilead-maps-out-its-oncology-ambitions-seeing-33-revenue-coming-oncology-drugs-2030
https://investors.gilead.com/static-files/332d0c81-fa18-44fa-82d3-babf96ca12d0